UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating microRNAs as potential new biomarkers for prostate cancer

British journal of cancer, 2013-05, Vol.108 (10), p.1925-1930

2013

Volltextzugriff (PDF)

Revising the role of the androgen receptor in breast cancer

Journal of molecular endocrinology, 2014-06, Vol.52 (3), p.R257-R265

2014

Volltextzugriff (PDF)

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression

Oncogene, 2008-05, Vol.27 (21), p.2941-2950

2008

Volltextzugriff (PDF)

HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions

Oncogene, 2010-01, Vol.29 (3), p.411-420

2010

Volltextzugriff (PDF)

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

Oncogene, 2007-03, Vol.26 (12), p.1757-1768

2007

Volltextzugriff (PDF)

Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer

Journal of endocrinology, 2023-03, Vol.256 (3)

2023

Volltextzugriff (PDF)

High fat diet causes distinct aberrations in the testicular proteome

International Journal of Obesity, 2020-09, Vol.44 (9), p.1958-1969

2020

Volltextzugriff (PDF)

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

Molecular cancer, 2022-03, Vol.21 (1), p.82-22, Article 82

2022

Volltextzugriff (PDF)

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens

Oncogene, 2012-10, Vol.31 (43), p.4588-4598

2012

Volltextzugriff (PDF)

Notch signaling: a potential therapeutic target in prostate cancer

Current cancer drug targets, 2008-11, Vol.8 (7), p.566-580

2008

Volltextzugriff (PDF)

The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

Molecular and Cellular Biology, 1999-12, Vol.19 (12), p.8383-8392

1999

Volltextzugriff (PDF)

Phenotypic diversity in siblings with partial androgen insensitivity syndrome

Archives of disease in childhood, 1997-06, Vol.76 (6), p.529-531

1997

Volltextzugriff (PDF)

Functional Analysis of Six Androgen Receptor Mutations Identified in Patients with Partial Androgen Insensitivity Syndrome

Human molecular genetics, 1996-02, Vol.5 (2), p.265-273

1996

Volltextzugriff (PDF)

Mechanisms of androgen receptor repression in prostate cancer

Biochemical Society transactions, 2006-12, Vol.34 (Pt 6), p.1124-1127

2006

Volltextzugriff (PDF)

Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers

Endocrine-related cancer, 2014-10, Vol.21 (5), p.R409-R429

2014

Volltextzugriff (PDF)

Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome

The Journal of steroid biochemistry and molecular biology, 1997-04, Vol.61 (1), p.19-26

1997

Volltextzugriff (PDF)

Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor

Molecular and Cellular Biology, 2005-02, Vol.25 (4), p.1425-1436

2005

Volltextzugriff (PDF)

Androgens target prohibitin to regulate proliferation of prostate cancer cells

Oncogene, 2004-04, Vol.23 (17), p.2996-3004

2004

Volltextzugriff (PDF)

Androgen receptor in prostate cancer: cause or cure?

Trends in endocrinology and metabolism, 2005-11, Vol.16 (9), p.395-397

Bevan, Charlotte L.

2005

Volltextzugriff (PDF)

Androgen Receptor Is Targeted to Distinct Subcellular Compartments in Response to Different Therapeutic Antiandrogens

Clinical cancer research, 2004-11, Vol.10 (21), p.7392-7401

2004

Volltextzugriff (PDF)

MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data

British journal of cancer, 2022-02, Vol.126 (3), p.502-513

2022

Volltextzugriff (PDF)

Vitamin D and Gut Health

Advances in experimental medicine and biology, 2022, Vol.1390, p.155-167

2022

Volltextzugriff (PDF)

Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination

British journal of cancer, 2014-09, Vol.111 (7), p.1338-1349

2014

Volltextzugriff (PDF)

Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.1282-1290

2014

Volltextzugriff (PDF)

1 – 25 von 247

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(206)

Publikationsform

Artikel
(246)
Tagungsberichte
(1)

Sprache

Englisch
(247)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating microRNAs as potential new biomarkers for prostate cancer

Revising the role of the androgen receptor in breast cancer

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression

HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer

High fat diet causes distinct aberrations in the testicular proteome

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens

Notch signaling: a potential therapeutic target in prostate cancer

The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

Phenotypic diversity in siblings with partial androgen insensitivity syndrome

Functional Analysis of Six Androgen Receptor Mutations Identified in Patients with Partial Androgen Insensitivity Syndrome

Mechanisms of androgen receptor repression in prostate cancer

Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers

Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome

Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor

Androgens target prohibitin to regulate proliferation of prostate cancer cells

Androgen receptor in prostate cancer: cause or cure?

Androgen Receptor Is Targeted to Distinct Subcellular Compartments in Response to Different Therapeutic Antiandrogens

MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Vitamin D and Gut Health

Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination

Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

Aktive Filter

Suchergebnisse filtern